Executive Overview
In a landmark legal ruling that threatens to disrupt the multi-billion-dollar pet food market, a U.S. Federal Court of Appeals has reinstated a high-stakes lawsuit brought by KetoNatural Pet Foods against industry heavyweight Hill’s Pet Nutrition. The suit alleges that Hill’s—working in conjunction with a network of veterinary researchers and academic partners—executed an aggressive, deceptive misinformation campaign designed to falsely link grain-free dog foods produced by independent manufacturers to a fatal canine heart condition known as Dilated Cardiomyopathy (DCM).
The complaint, originally filed in February 2024, outlines an intricate, corporate-driven strategy to weaponize scientific ambiguity, influence regulatory bodies like the U.S. Food and Drug Administration (FDA), and terrify pet owners into abandoning boutique and grain-free brands. While a district court initially dismissed the complaint, the Appeals Court reversed the decision, determining that KetoNatural had plausibly alleged that Hill’s engaged in false advertising and commercial speech designed to unlawfully eliminate market competitors.
Adding a dramatic turn to the proceedings, recently surfaced scientific documentation reveals that Hill’s conducted its own comprehensive, 18-month feeding study between 2019 and 2021, which concluded that grain-free diets do not cause DCM or impair canine heart function. However, Hill’s sat on the research for four years, suppressing the findings until July 2025—long after the initial panic had decimated independent market share and reshaped consumer buying habits across the country.
Detailed Chronology
+-----------------------------------------------------------------------------------+
| CHRONOLOGY OF EVENTS |
+-----------------------------------------------------------------------------------+
| 2018–2019 : FDA issues public alerts regarding potential links between DCM & |
| grain-free dog foods, triggering widespread industry panic. |
| |
| Dec 2019 : Hill's Pet Nutrition initiates a prospective 18-month double-blind |
| feeding trial to evaluate grain-free vs. grain-inclusive diets. |
| |
| Aug 2021 : Hill's trial finishes; data confirms grain-free diets support normal |
| cardiac function. Study remains unpublished. |
| |
| Feb 2024 : KetoNatural files a 124-page federal complaint against Hill's, |
| alleging false advertising and anti-competitive misinformation. |
| |
| Mid-2024 : District Court dismisses KetoNatural's complaint; KetoNatural files |
| an immediate appeal. |
| |
| Early 2025: Court of Appeals rules in favor of KetoNatural, reversing dismissal |
| and greenlighting the lawsuit to proceed. |
| |
| July 2025 : Hill's internal 2019–2021 trial is finally published, publicly |
| confirming no link between grain-free diets and canine DCM. |
+-----------------------------------------------------------------------------------+The Origins of the Panic (2018–2019)
The dispute stems from a multi-year controversy surrounding canine Dilated Cardiomyopathy (DCM), a condition characterized by the enlargement and weakening of the heart muscle. Beginning around 2018, public alerts issued by the FDA highlighted a potential connection between non-hereditary DCM and dog foods labeled as "grain-free," which often substituted corn, wheat, and soy with pulse crops (such as lentils and peas) or potatoes. Major market incumbents—primarily Hill’s Pet Nutrition, Purina, and Mars Petcare—heavily leveraged these warnings, positioning their own grain-inclusive, corn-based formulations as the only scientifically validated, safe option for pets.
The Filing of the Lawsuit (February 2024)
In February 2024, KetoNatural Pet Foods—a small, independent manufacturer specializing in low-carbohydrate, grain-free pet food—filed a comprehensive 124-page federal lawsuit against Hill’s Pet Nutrition. The filing alleged that Hill’s had orchestrated a manufactured health crisis to reclaim market share lost to innovative, independent boutique brands over the preceding decade.
KetoNatural argued that Hill’s selectively curated data, funded biased academic circles, and funneled unvetted case reports to the FDA to provoke public agency alerts, effectively weaponizing federal regulatory communications to crush its smaller rivals.
Dismissal and Reinstatement on Appeal
The lawsuit initially faced a setback when the lower district court granted Hill’s motion to dismiss. Hill’s maintained that its public statements regarding grain-free diets and DCM were protected academic discourse and non-commercial scientific opinions rather than commercial advertising.
KetoNatural appealed the dismissal to the United States Court of Appeals for the Tenth Circuit. Reversing the lower court’s ruling, the appellate panel ruled that the suit must proceed. The court rejected Hill’s argument, holding that KetoNatural had plausibly demonstrated that Hill’s promotional materials, website claims, and public messaging constituted false and misleading commercial speech aimed directly at shifting purchasing decisions.
The Delayed Research Revelation (July 2025)
The legal victory coincided with an unexpected development in the scientific record. In July 2025, a peer-reviewed study titled "Different carbohydrate sources in dog foods supported overall health and cardiac function: an 18-mo prospective study in healthy adult dogs" was officially published.
The study, fully funded by Hill’s Pet Nutrition and authored entirely by current and former Hill’s scientists, concluded that grain-free and grain-inclusive diets both supported normal cardiac function without causing heart disease. Crucially, metadata revealed that the clinical trials ran from December 2, 2019, to August 25, 2021. Hill’s had held the conclusive data internally for four years before releasing it to the veterinary community and the public.
Supporting Context & Market Metrics
The Economic Mechanics of the "DCM Scare"
To understand the legal battle, one must examine the shifts in the pet food market over the past two decades. Prior to the 2018 DCM alerts, independent brands offering raw, high-meat, and grain-free formulas experienced explosive growth. Consumers increasingly viewed traditional, grain-heavy kibble—predominantly manufactured by traditional industry giants—as filled with low-cost fillers like corn and gluten.
HISTORICAL MARKET SHARE SHIFT (APPROXIMATE TRENDS)
Market Share (%)
100 |============================== ==============================
| Legacy Giants (Hill's, Mars, | | Legacy Giants Reclaim |
80 | Purina) Dominance | | Dominance via DCM Scare |
| | | |
60 | | | |
| | | |
40 | /------------------+---->| Boutique / Grain-Free |
| / Rise of Boutique | | Market Collapses |
20 | / & Grain-Free | | |
|________/_____________________|_____|____________________________|
2010 2015 2018 2020 2025When allegations connecting grain-free diets to DCM emerged, sales for boutique manufacturers plummeted. Consumers, terrified by headlines and veterinary warnings, fled back to legacy brands. The suit claims this panic was engineered to convince dog owners that common feed grains like corn were critical preventative ingredients against cardiac collapse, effectively protecting legacy market dominance.
Key Metrics of the Undisclosed Clinical Trial
The delayed study represents a key piece of evidence in KetoNatural’s ongoing litigation. The methodological and operational footprint of the trial highlights the gap between Hill’s public communications and its internal scientific data:
| Study Metric | Specification / Details |
|---|---|
| Study Title | Different carbohydrate sources in dog foods supported overall health and cardiac function: an 18-mo prospective study in healthy adult dogs |
| Sponsor / Funding | Hill’s Pet Nutrition, Inc. |
| Author Affiliations | 100% current or former employees of Hill’s Pet Nutrition |
| Trial Design | Prospective, double-blind, randomized, parallel-group trial |
| Trial Duration | December 2, 2019 – August 25, 2021 (18 months) |
| Publication Date | July 2025 |
| Publication Gap | 3 years, 11 months (from trial end to publication) |
| Primary Conclusion | Both grain-free and grain-inclusive diets support normal cardiac function with zero evidence of diet-induced DCM. |
Official Statements & Judicial Findings
The legal documents filed in the case highlight the opposing positions of the parties involved and reflect the Appellate Court’s decision to allow the suit to proceed.
Excerpts from KetoNatural’s Federal Complaint
In its initial 124-page filing, KetoNatural paints a detailed picture of corporate manipulation, alleging that Hill’s deliberately fostered a public health crisis to line its pockets:
"This lawsuit concerns an egregious, wide-ranging, and damaging campaign of coordinated, for-profit, faux-scientific misinformation by a large corporation. They carried out a scheme to falsely convince American dog owners that a massive, unrelated, and hugely diverse group of dog food products—essentially any product made by any of the hundreds of independent firms that were collectively eroding Hill’s market share—all increase the risk and severity of a deadly canine heart disease called dilated cardiomyopathy (‘DCM’)."
Findings from the Tenth Circuit Court of Appeals
In overruling the district court’s initial dismissal, the Appeals Court focused on the commercial nature of Hill’s public marketing and online resources, which repeatedly cited DCM risks to dissuade pet owners from purchasing boutique brands:
"KetoNatural has plausibly alleged that some statements and links on Hill’s webpages are commercial speech. KetoNatural has also plausibly alleged that these statements are literally false."
Perspective from Consumer Advocacy Groups
Susan Thixton, a prominent pet food consumer advocate and founder of TruthaboutPetFood.com, highlighted the significance of the Appeals Court decision and criticized the delay in releasing the study results:
"This lawsuit will be VERY interesting to watch play out. It will give pet owners an inside look into what some manufacturers will do to make money—the lengths they go through, the schemes they develop to manipulate the public… Keto Natural Pet Food had the courage to take the issue to court, to hold those who allegedly put this scheme together accountable."
Future Outlook & Industry Implications
As the case moves back to the federal district court for discovery, legal and pet industry analysts anticipate unprecedented access to internal corporate communications, veterinary consulting agreements, and historical strategy documents from Hill’s Pet Nutrition.
+-----------------------------------------------------------------------------------+
| POTENTIAL INDUSTRY RIPPLE EFFECTS |
+-----------------------------------------------------------------------------------+
| 1. DISCOVERY & INTERNAL EMAILS |
| Subpoenas may force publication of internal communications between legacy |
| manufacturers, veterinary key opinion leaders, and regulatory liaisons. |
| |
| 2. VETERINARY PRACTICES RE-EVALUATION |
| Veterinary networks may need to revise nutritional counseling guidelines |
| that penalize grain-free diets based on outdated 2018 alerts. |
| |
| 3. CLASS-ACTION & COMPETITOR LITIGATION |
| A victory for KetoNatural could open the floodgates for similar antitrust |
| and tortious interference suits from other independent pet food makers. |
| |
| 4. REGULATORY TRANSPARENCY |
| Increased scrutiny on how the FDA handles anecdotal veterinary reports and |
| industry-funded scientific submissions going forward. |
+-----------------------------------------------------------------------------------+Unpacking the Discovery Phase
With the dismissal successfully overturned, KetoNatural now has the legal authority to request internal documentation through the discovery process. Subpoenas are expected to target internal communications from late 2018 through 2025, specifically seeking details on:
- The decision-making process behind delaying the publication of the 2019–2021 feeding trial.
- Financial relationships and sponsorship contracts between legacy manufacturers and academic veterinary nutritionists who publicly sounded the alarm on DCM.
- Strategic communications with FDA officials regarding the drafting and timing of public DCM updates.
Impact on Veterinary Medicine and Consumer Trust
For nearly seven years, the narrative that "grain-free food causes DCM" was widely accepted across clinics nationwide. Many veterinary professionals advised pet owners to avoid independent brands and stick strictly to diets manufactured by major industry brands like Hill’s, Royal Canin (Mars), and Pro Plan (Purina).
The publication of Hill’s own 2019–2021 trial, alongside the ongoing lawsuit, is forcing a reassessment within the veterinary community. Practitioners are now confronted with peer-reviewed proof that grain-free formulations meeting standard nutritional guidelines do not harm cardiac health.
As the lawsuit proceeds, it promises to serve as a pivotal moment for transparency within the pet food industry, raising fundamental questions about how scientific research is funded, controlled, and leveraged in the marketplace.
